Loading company…
Metyos is developing an arm-worn device to monitor biomarkers associated with kidney disease.
Metyos is developing a wearable patch that senses ions and minerals in the bloodstream and sends data to an app and secure cloud server for healthcare professionals to monitor remotely. Founded in 2021, the company is based in Paris, France, and raised EUR 2.3 million in pre-seed funding in March 2024, led by Cenitz, with Bpifrance, ADVANS Group and KIMA Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in